Kura Oncology, Inc. Share Price

Kura Oncology, Inc. Share Price

NASDAQ: KURA | Small Cap
$10.57
-$0.13 (-1.21%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kura Oncology, Inc. Stock Performance

Open
$10.74
Prev. Close
$10.70
Circuit Range
N/A
Day Range
$10.51 - $10.92
Year Range
$7.36 - $13.89
Volume
93,457
Average Traded
$10.64

Kura Oncology, Inc. Share Price Today

As of 30 October 2026, Kura Oncology, Inc.'s share price is $10.57. The stock opened at $10.74, compared to its previous close of $10.70. During today's trading session, Kura Oncology, Inc.'s share price traded between $10.51 and $10.92, with an average price of $10.71. Over the past 52 weeks, the stock has recorded a high of $13.89 and a low of $7.36. In terms of performance, Kura Oncology, Inc.'s share price has risen by 19.71% over the last six months and is up 3.02% on a year-on-year basis.

Kura Oncology, Inc. Share Price Chart

Line chart of the Kura Oncology, Inc. price trend over the selected period. The price fell overall, ranging from 10.52 to 10.92, ending at 10.55.
$10.51$10.92
L
Show Current Price
H

Kura Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap
$926.74M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.34
Revenue (TTM)
$67.48B
Return On Equity (TTM)
-612.78%
Profit Margin
-412.97%
Debt to Equity
0.20
Quarterly Earnings Growth YoY
7.81%

Kura Oncology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$20.75$17.34$18.27$20.87
Net Profit-$74.12-$81.00-$73.33-$68.33
Net Profit Margin-357.20%-467.13%-401.37%-327.41%
Income ChangeN/A-9.28%9.47%6.82%

Kura Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$53.88$67.48
Net Profit-$135.84-$152.63-$173.98-$278.67
Net Profit MarginN/AN/A-322.90%-412.97%
Income ChangeN/A-12.36%-13.99%-60.17%

About Kura Oncology, Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Kura Oncology, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$10.89
$10.56
-1.26%
Sep 2026
$12.65
$10.70
-18.79%
Aug 2026
$8.92
$13.18
+46.06%
Jul 2026
$10.99
$9.02
-17.70%
Jun 2026
$9.97
$10.96
+7.35%
May 2026
$8.74
$10.21
+15.63%
Apr 2026
$8.21
$8.83
+8.61%
Mar 2026
$8.72
$8.13
-6.87%
Feb 2026
$8.08
$8.73
+7.53%
Jan 2026
$10.36
$8.12
-21.78%
Dec 2025
$12.05
$10.38
-14.64%
Nov 2025
$10.33
$12.16
+18.52%

KURA Share Price FAQs